Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-037889
Filing Date
2021-06-03
Accepted
2021-06-03 18:28:22
Documents
1
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7715
  Complete submission text file 0001209191-21-037889.txt   9447
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142
Business Address
Smith Michael David (Reporting) CIK: 0001777800 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 21994055